Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 7, 1998 - Issue 4
Submit an article Journal homepage
45
Views
20
CrossRef citations to date
0
Altmetric
Miscellaneous

Potential therapeutic applications of fructose-1,6-diphosphate

Paul J Marangos Cypros Pharmaceutical Corporation, 2714 Loker Avenue West, Carlsbad, CA 92008, USA.
,
Anthony W Fox Cypros Pharmaceutical Corporation, 2714 Loker Avenue West, Carlsbad, CA 92008, USA.
,
Bernhard J Riedel Cypros Pharmaceutical Corporation, 2714 Loker Avenue West, Carlsbad, CA 92008, USA.
,
David Royston Cypros Pharmaceutical Corporation, 2714 Loker Avenue West, Carlsbad, CA 92008, USA.
&
Zofia E Dziewanowska Cypros Pharmaceutical Corporation, 2714 Loker Avenue West, Carlsbad, CA 92008, USA.
Pages 615-623 | Published online: 23 Feb 2005

  • LAZAR HL: Enhanced preservation of acutely ischemic myocardium and improved clinical outcomes using glucose-insulin-potassium (GM) solutions. Am. J. Car-diol. (1997) 80(3A):90A–93A.
  • HOFMANN E: The significance of phosphofructoki-nase to the regulation of carbohydrate metabolism. Rev. Physiol. Biochem. Pharmacol (1976) 75:2–68.
  • KUBLER W, SPIECKERMANN PG: Regulation of glycoly-sis in the ischemic and anoxic myocardium. J. Mol Cell Cardiol. 1:351–377.
  • TAVAZZI B, STARNES JW, LAZZARINO G et al: Exoge-nous fructose-1,6-biphosphate is a metabolizable sub-strate for the isolated normoxic rat heart. Basic Res. Cardiol. (1992) 87:280–289.
  • FARIAS LA, SMITH EE, MARKOV AK: Prevention of ischemic-hypoxic brain injury and death in rabbits with fructose-1,6-diphosphate. Stroke (1990) 21:606–613.
  • GREGORY GA, YU ACH, CHAN PH: Fructose-1,6-biphosphate protects astrocytes from hypoxic dam-age. Cereb. Blood Flow Metab. (1989) 9:29–34.
  • HARDIN CD, ROBERTS TM: Metabolism of exogenously applied fructose-1,6-diphosphate in hypoxic vascular smooth muscle. Am J. Physiol. (1994) 267:H2325–2332.
  • GREGORY GA, WELSH FA, YU ACH, CHAN PH: Fructose-1,6-biphosphate reduces ATP loss from hy-poxic astrocytes. Brain Res. (1990) 516:310–312.
  • PAUL RJ, HARDIN CD, RAEYMAEKERS L, WUYTACK F, CASTEELS R: Preferential support of Ca2±uptake in smooth muscle plasma membrane vesicles by an en-dogenous glycolytic cascade. FASEB J. (1989) 3:2298–2301.
  • EDDE L, ZHOU X, EATON JW, SHERMAN MP: Induction of nitric oxide synthase in macrophages: inhibition by fructose-1,6-diphosphate. BBRC (1998). (In Press.)
  • MIHAS AA, MALIAKKAL RJ, MIHAS TA, KANJI VK, MAR-KOV AK: Effects of fructose-1,6-diphosphate on the ac-tivity of rat liver nitric oxide synthase in vitro. Pharmacology (1997) 54:43–48.
  • LAZZARINO G, NUUTINEN ME, TAVAZZI B et al.: Preserv-ing effect of fructose-1, 6-biphosphate on high-energy phosphate compounds during anoxia and reperfu-sion in isolated Langendorff-perfused rat hearts. J. Mol. Cell Cardiol (1991) 23:13–23.
  • ZHANG JM, ZHANG FM, MA WS, FORRESTER T: Protective effects of exogenous fructose-1,6-diphosphate in car-diogenic shock. Cardiovasc. Res. (1988) 22:927–932.
  • URSO L, BRILLANTE C, ORLANDI M, ROTUNDO M, BAL- LATI S: Evaluation of fructose-1,6-diphosphate effects on erythrocyte 2,3-diphosphoglycerate and ATP in surgical orthopedic patients. Agressologie (1982) 23:115–117.
  • BADWEY JA, KARNOVSKY ML: Production of superox-ide and hydrogen peroxide by an NADH-oxidase in guinea pig polymorphonuclear leukocytes. J. Biol. Chem. (1979) 254:11530–11537.
  • CACIOLI D, CLIVATI A, PELOSI P, MEGEVAND J, GALEONE M: Haemorheological effects of fructose-1,6-diphosphate in patients with lower extremity ische-mia. Curr. Med. Res. Opin. (1988) 10:668–674.
  • TAVAZZI B, CERRONI L, DI PIERRO D et al.: Oxygen radi-cal injury and loss of high-energy compounds in an-oxic and reperfused rat heart: prevention by exogenous fructose-1,6-biphosphate. Free Rad. Res. Comm. (1990) 10:167–176.
  • MARKOV AK, FINCH CD, HELLEMS HK: Prevention of su-peroxide generation and inhibition of oxygen burst in human canine neutrophils with fructose-1,6-diphosphate (EDP). In: Microcirculation: An Update Vol-ume 1. Tsuchiya M, Asano M, Mishima Y, Oda M (Eds.), El-sevier, Amsterdam (1987):692–696.
  • MARKOV AK, DIDLAKE RH et al: Prevention of free radicals-induced pulmonary damage with fructose-1,6-diphosphate (EDP). Clin. Res. (1986) 34 (10):227A.
  • JANZ TG, LEASURE J, OLSON JE: The effects of fructose-1,6-diphosphate on myocardial damage in acute coronary artery occlusion. Resuscitation (1991) 22:45–54.
  • ANGELOS M, LEASURE J, BARTON R: Fructose-1,6-diphosphate fails to limit early myocardial infarction size in a canine model. Ann. Emerg. Med. (1993) 22:171–177.
  • SUN J, FARIAS LA, MARKOV AK: Fructose-1,6-diphosphate prevents intestinal ischemic reperfusion injury and death in rats. Gastroenterology (1990) 98:117–126.
  • TRIMARCHI GR, DE LUCA R, CAMPO M, SCURI R, CAPUTIAP: Protective effects of fructose-1,6-biphosphate on survival and brain putrescine levels during ischemia and recirculation in the Mongolian gerbil. Stroke (1990) 21:171–173.
  • MARCHIONNI N, CONTI A, DE ALFIERI W et al. Hemody- namic and electrocardiographic effects of fructose-1,6-diphosphate in acute myocardial infarc-tion. Am. J. Cardiol. (1985) 56:266–269.
  • MARKOV AK, BRUMLEY MA, FIGUEROA A, SKELTON TN, LEHAN PH: Hemodynamic effects of fructose-1,6-diphosphate in patients with normal and impaired left ventricular function. Am. HeartJ (1997) 133 (5):541–549.
  • YI WS, HONG DR: Effect of fructose-1,6-diphosphate on mortality in patients with acute myocardial infarction. Abstract submitted to American College of Cardiology 41st Scientific Session. (1992):904–963.
  • MARCHIONNI N, MOSCHI G, DI BARI M et al.: Improved exercise tolerance by IV fructose-1,6-diphosphate in chronic stable angina pectoris. J. Clin. Pharmacol. (1988) 28:807–811.
  • GRANDI AM, MUGGIA C, BARZIZZA F, VENCO A, FINARDI G: Improved left ventricular function after short-term treatment with fructose-1,6-diphosphate: echocardio-graphic study in chronic ischemic heart disease and idiopathic dilated cardiomyopathy. Clin. Therap. (1988) 10:372–380.
  • MALUSARDI R, ODDONE A, ORLANDI M, MANZI G: Fructose-1,6-diphosphate in the treatment of atrial pacing induced myocardial ischemia. Minerva Cardio-angiologica (1988) 36:439–444.
  • ODERO A, KUNKL E, CUGNASCA M, DE AMICIS P, PECIS C, MARCHETTI M: Fructose-1,6-diphosphate in peripheral vascular disease: a clinical evaluation in lower limb ischemia. Curr. Ther. Res. (1985) 38:396–403.
  • NUUTINEN EM, LAZZARINO G, GIARDINA B, HASSINEN IE: Effect of exogenous fructose-1,6-biphosphate on glycolysis in the isolated perfused rat heart. Am. Heart J. (1991) 122:523–527.
  • RIEDEL B, SACCO C, FOX AW, ELLIS G, ROYSTON D: Myo-cardial performance preservation by fructose-1,6-diphosphate (EDP) following cardiopulmonary by-pass. Anesthesiology (September, 1996) Abstract 85: (3A).
  • BUNN FH: Pathogenesis and treatment of sickle cell disease. New Engl. J. Med. (1997) 9:762–769.
  • SOLOVEY A, LIN YI, BROWNE P et al.: Circulating acti-vated endothelial cells in sickle cell anemia. NewEngLJ. Med. (1997) 11:1584–1590.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.